AMICUS THERAPEUTICS, INC.
Board Member, CEO, COO
Board Member
AMICUS THERAPEUTICS, INC.
CEO
AMICUS THERAPEUTICS, INC.
COO
AMICUS THERAPEUTICS, INC.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Bradley Campbell is recorded as Board Member, CEO and COO at AMICUS THERAPEUTICS, INC.. The proxy statement of AMICUS THERAPEUTICS, INC. reports total compensation of $8,526,943 for Bradley Campbell in fiscal 2024, including a base salary of $767,308. Disclosed compensation is on record for 3 fiscal years. Bradley Campbell has spoken on 22 earnings calls across 1 company, most recently for AMICUS THERAPEUTICS, INC. on November 4, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
AMICUS THERAPEUTICS, INC.
Board Member
Proxy statement
AMICUS THERAPEUTICS, INC.
CEO
Proxy statement
AMICUS THERAPEUTICS, INC.
COO
Proxy statement
Recorded roles and call appearances connecting this person to public companies.
AMICUS THERAPEUTICS, INC.
Board Member, CEO, COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | AMICUS THERAPEUTICS, INC. | President and Chief Executive Officer | $767,308 | $8,526,943 |
| 2023 | AMICUS THERAPEUTICS, INC. | President and Chief Executive Officer | $698,558 | $8,202,366 |
| 2022 | AMICUS THERAPEUTICS, INC. | President and Chief Executive Officer | $591,040 | $8,997,866 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
AMICUS THERAPEUTICS, INC. Q3 FY2025 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q2 FY2025 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q1 FY2025 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q4 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q3 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q2 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q1 FY2024 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q4 FY2023 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q3 FY2023 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q2 FY2023 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q1 FY2023 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q4 FY2022 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q3 FY2022 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q2 FY2022 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q1 FY2022 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q4 FY2021 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q3 FY2021 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q2 FY2021 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q4 FY2020 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q3 FY2020 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q2 FY2020 Earnings Call
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. Q1 FY2020 Earnings Call
AMICUS THERAPEUTICS, INC.